Targeting tumor angiogenesis with histone deacetylase inhibitors
Solid tumor malignancies including breast, lung and prostate carcinomas are considered to
be angiogenesis dependent. Tumor angiogenesis is often mediated by hypoxia secondary …
be angiogenesis dependent. Tumor angiogenesis is often mediated by hypoxia secondary …
Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma
PK Ha, JA Califano - The lancet oncology, 2006 - thelancet.com
Genetic alterations that lead to loss or changes in tumour-suppressor genes are known to
contribute to oral carcinogenesis. Traditional molecular methods to detect such losses have …
contribute to oral carcinogenesis. Traditional molecular methods to detect such losses have …
Epigenetic mechanisms in oral carcinogenesis
JA Gasche, A Goel - Future oncology, 2012 - Taylor & Francis
Dysregulation of gene expression is a frequent occurrence in oral squamous cell carcinoma
(OSCC). However, accumulating evidence suggests that in contrast to genetics, epigenetic …
(OSCC). However, accumulating evidence suggests that in contrast to genetics, epigenetic …
Epigenetic disregulation in oral cancer
M Mascolo, M Siano, G Ilardi, D Russo… - International journal of …, 2012 - mdpi.com
Squamous cell carcinoma of the oral region (OSCC) is one of the most common and highly
aggressive malignancies worldwide, despite the fact that significant results have been …
aggressive malignancies worldwide, despite the fact that significant results have been …
Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
S Shankar, RK Srivastava - Advances in experimental medicine and …, 2008 - europepmc.org
Epigenic modifications, mainly DNA methylation and acetylation, are recognized as the main
mechanisms contributing to the malignant phenotype. Acetylation and deacetylation are …
mechanisms contributing to the malignant phenotype. Acetylation and deacetylation are …
Fragmentation-based methods and systems for sequence variation detection and discovery
D Van Den Boom, S Boecker - US Patent 7,820,378, 2010 - Google Patents
US7820378B2 - Fragmentation-based methods and systems for sequence variation detection
and discovery - Google Patents US7820378B2 - Fragmentation-based methods and systems …
and discovery - Google Patents US7820378B2 - Fragmentation-based methods and systems …
DNA methyltransferases as targets for cancer therapy.
K Ghoshal, S Bai - Drugs of Today (Barcelona, Spain: 1998), 2007 - europepmc.org
Methylation of DNA at 5-position of cytosine, catalyzed by DNA methyltransferases, is the
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …
Dual targeting of epigenetic therapy in cancer
DMEI Hellebrekers, AW Griffioen… - Biochimica et Biophysica …, 2007 - Elsevier
Aberrant epigenetic silencing of tumor suppressor genes by promoter DNA
hypermethylation and histone deacetylation plays an important role in the pathogenesis of …
hypermethylation and histone deacetylation plays an important role in the pathogenesis of …
Maspin: molecular mechanisms and therapeutic implications
TM Bodenstine, REB Seftor, Z Khalkhali-Ellis… - Cancer and Metastasis …, 2012 - Springer
Maspin, a non-inhibitory member of the serine protease inhibitor superfamily, has been
characterized as a tumor suppressor gene in multiple cancer types. Among the established …
characterized as a tumor suppressor gene in multiple cancer types. Among the established …
Epigenetic regulation in oral squamous cell carcinoma microenvironment: a comprehensive review
H Mesgari, S Esmaelian, K Nasiri, S Ghasemzadeh… - Cancers, 2023 - mdpi.com
Simple Summary This comprehensive review focuses on the role of epigenetics in oral
squamous cell carcinoma (OSCC), a prevalent type of oral cancer. The review highlights the …
squamous cell carcinoma (OSCC), a prevalent type of oral cancer. The review highlights the …